REACT clinical trial supports new approach of accelerated treatment for Crohn’s disease – The final results from an international clinical trial involving nearly 2,000 patients with Crohn’s disease support the use of a new management strategy referred to as accelerated step-care as a best practice for the care of active Crohn’s disease.
Studies show vedolizumab is an effective treatment for Crohn’s disease and ulcerative colitis – Investigational antibody vedolizumab is an effective treatment for those suffering from ulcerative colitis (UC) and Crohn’s disease (CD) when other treatments have failed, revealed in an international clinical trial.
Work with your health care provider to find out what your personal risk is and how often you should be screened. Have you had your colon cancer screening test? – March is National Colorectal Cancer Awareness Month in US. “Colon cancer can be prevented with screening and removal of any polyps before they develop into cancer” says Sheryl M. Ness, R.N., Mayo Clinic nurse educator.
Aspirin may decrease risk of aggressive form of ovarian cancer – New research shows that women who regularly use pain relief medications, particularly aspirin, have a decreased risk of serous ovarian cancer?an aggressive carcinoma affecting the surface of the ovary, published in Acta Obstetricia et Gynecologica Scandinavica.
No evidence that drug used for preventing life-threatening bleeding in women during labor works — Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage – There is insufficient evidence for the effectiveness of a drug that is being used increasingly to prevent life-threatening bleeding in women after giving birth in community settings in low income countries.
FDA approves Zaltrap for metastatic colorectal cancer – The U.S. Food and Drug Administration approved Zaltrap (ziv-aflibercept) for use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.
Study shows higher healing rate using unique cell-based therapy in chronic venous leg ulcers – Treating chronic venous leg ulcers with a topical spray containing a unique living human cell formula provides a 52 percent greater likelihood of wound closure than treatment with compression bandages only.
FDA approves Remicade to treat ulcerative colitis in children older than 6 years – The U.S. Food and Drug Administration approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.